Karen E. Swales

Farnesoid X Receptor Ligands Inhibit Vascular Smooth Muscle Cell Inflammation and Migration

Yoyo T.Y. Li, Karen E. Swales, Gareth J. Thomas et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 169 citations

Life Sciences, Molecular Biology, Pharmacology +17

The Farnesoid X Receptor Is Expressed in Breast Cancer and Regulates Apoptosis and Aromatase Expression

Karen E. Swales, Márta Korbonits, R Carpenter et al. · Cancer Research · 2006 · 154 citations · Full text

Medicine, Oncology, Pharmacology +15

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors

Joaquı́n Mateo, Gopinath Ganji, Charlotte Lemech et al. · Clinical Cancer Research · 2017 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with <i>BRCA1/2</i> - and Non– <i>BRCA1/2</i> -Mutant Cancers

Timothy A. Yap, Rebecca Kristeleit, Vasiliki Michalarea et al. · Cancer Discovery · 2020 · 134 citations · Full text

Medicine, Oncology, Pharmacology +13

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Christina Guo, Adam Sharp, Bora Gürel et al. · Nature · 2023 · 120 citations · Full text

Medicine, Oncology, Pharmacology +17